Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers
NCT03125473
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Norovirus Gastroenteritis
Interventions
BIOLOGICAL:
VXA-G1.1-NN Oral Vaccine
Sponsor
Vaxart